A role for tau at the synapse in Alzheimer's disease pathogenesis

Neuropharmacology

Volumn 76, Issue PART A, 2014, Pages 1-8

  Pooler, Amy M ^a   Noble, Wendy ^a   Hanger, Diane P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Neurodegeneration; Synapse; Synaptotoxicity; Tau

Indexed keywords

AMYLOID PROTEIN; KINESIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; SYNAPTOPHYSIN; TAU PROTEIN;

ALZHEIMER DISEASE; DENDRITE; DENDRITIC SPINE; DISEASE COURSE; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MOLECULAR DOCKING; NERVE FIBER; NONHUMAN; OLIGOMERIZATION; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

ALZHEIMER'S DISEASE; NEURODEGENERATION; SYNAPSE; SYNAPTOTOXICITY; TAU;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; MITOCHONDRIA; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TAU PROTEINS;

EID: 84886509822     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.09.018     Document Type: Review

References (120)

1. C. Andorfer, Y. Kress, M. Espinoza, R. de Silva, K.L. Tucker, Y.A. Barde, K. Duff, and P. Davies Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J. Neurochem. 86 2003 582 590 (Pubitemid 36897439)
2. T. Arendt Synaptic degeneration in Alzheimer's disease Acta Neuropathol. 118 2009 167 179
3. I. Begcevic, H. Kosanam, E. Martinez-Morillo, A. Dimitromanolakis, P. Diamandis, U. Kuzmanov, L.N. Hazrati, and E.P. Diamandis Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains Clin. Proteomics 10 2013 5
4. K.F. Bell, D.A. Bennett, and A.C. Cuello Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment J. Neurosci. 27 2007 10810 10817 (Pubitemid 47535872)
5. Z. Berger, H. Roder, A. Hanna, A. Carlson, V. Rangachari, M. Yue, Z. Wszolek, K. Ashe, J. Knight, D. Dickson, C. Andorfer, T.L. Rosenberry, J. Lewis, M. Hutton, and C. Janus Accumulation of pathological tau species and memory loss in a conditional model of tauopathy J. Neurosci. 27 2007 3650 3662 (Pubitemid 46557687)
6. K. Bhaskar, S.H. Yen, and G. Lee Disease-related modifications in tau affect the interaction between fyn and tau J. Biol. Chem. 280 2005 35119 35125 (Pubitemid 41532698)
7. M. Bi, A. Ittner, Y.D. Ke, J. Gotz, and L.M. Ittner Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice PLoS One 6 2011 e26860
8. L.I. Binder, A. Frankfurter, and L.I. Rebhun The distribution of tau in the mammalian central nervous system J. Cell Biol. 101 1985 1371 1378 (Pubitemid 16203754)
9. A. Boutajangout, J. Ingadottir, P. Davies, and E.M. Sigurdsson Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain J. Neurochem. 118 2011 658 667
10. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
11. G.T. Bramblett, M. Goedert, R. Jakes, S.E. Merrick, J.Q. Trojanowski, and V.M. Lee Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding Neuron 10 1993 1089 1099 (Pubitemid 23194399)
12. R. Brandt, J. Leger, and G. Lee Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain J. Cell Biol. 131 1995 1327 1340
13. M.R. Brown, P.G. Sullivan, and J.W. Geddes Synaptic mitochondria are more susceptible to Ca2+overload than nonsynaptic mitochondria J. Biol. Chem. 281 2006 11658 11668 (Pubitemid 43855423)
14. L. Buee, T. Bussiere, V. Buee-Scherrer, A. Delacourte, and P.R. Hof Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res. Brain Res. Rev. 33 2000 95 130
15. L.M. Callahan, and P.D. Coleman Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease Neurobiol. Aging 16 1995 311 314
16. L.M. Callahan, W.A. Vaules, and P.D. Coleman Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles J. Neuropathol. Exp. Neurol. 58 1999 275 287 (Pubitemid 29140968)
17. X. Chai, J.L. Dage, and M. Citron Constitutive secretion of tau protein by an unconventional mechanism Neurobiol. Dis. 48 2012 356 366
18. X. Chai, S. Wu, T.K. Murray, R. Kinley, C.V. Cella, H. Sims, N. Buckner, J. Hanmer, P. Davies, M.J. O'Neill, M.L. Hutton, and M. Citron Passive immunization with anti-Tau antibodies in two transgenic models: reduction of tau pathology and delay of disease progression J. Biol. Chem. 286 2011 34457 34467
19. P.D. Coleman, and P.J. Yao Synaptic slaughter in Alzheimer's disease Neurobiol. Aging 24 2003 1023 1027 (Pubitemid 37487880)
20. L.N. Cooper, and M.F. Bear The BCM theory of synapse modification at 30: interaction of theory with experiment Nat. Rev. Neurosci. 13 2012 798 810
21. J.L. Crimins, A. Pooler, M. Polydoro, J.I. Luebke, and T.L. Spires-Jones The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease Ageing Res. Rev. 12 2013 757 763
22. J.L. Crimins, A.B. Rocher, and J.I. Luebke Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy Acta Neuropathol. 124 2012 777 795
23. J.L. Crimins, A.B. Rocher, A. Peters, P. Shultz, J. Lewis, and J.I. Luebke Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy Acta Neuropathol. 122 2011 551 564
24. I. Cuchillo-Ibanez, A. Seereeram, H.L. Byers, K.Y. Leung, M.A. Ward, B.H. Anderton, and D.P. Hanger Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin FASEB J. 22 2008 3186 3195
25. H.N. Dawson, A. Ferreira, M.V. Eyster, N. Ghoshal, L.I. Binder, and M.P. Vitek Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice J. Cell Sci. 114 2001 1179 1187 (Pubitemid 32288531)
26. A. de Calignon, M. Polydoro, M. Suarez-Calvet, C. William, D.H. Adamowicz, K.J. Kopeikina, R. Pitstick, N. Sahara, K.H. Ashe, G.A. Carlson, T.L. Spires-Jones, and B.T. Hyman Propagation of tau pathology in a model of early Alzheimer's disease Neuron 73 2012 685 697
27. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann. Neurol. 27 1990 457 464 (Pubitemid 20149963)
28. P. Derkinderen, T.M. Scales, D.P. Hanger, K.Y. Leung, H.L. Byers, M.A. Ward, C. Lenz, C. Price, I.N. Bird, T. Perera, S. Kellie, R. Williamson, W. Noble, R.A. Van Etten, K. Leroy, J.P. Brion, C.H. Reynolds, and B.H. Anderton Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase J. Neurosci. 25 2005 6584 6593 (Pubitemid 40995290)
29. M. Diaz-Hernandez, A. Gomez-Ramos, A. Rubio, R. Gomez-Villafuertes, J.R. Naranjo, M.T. Miras-Portugal, and J. Avila Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau J. Biol. Chem. 285 2010 32539 32548
30. C. Dillon, and Y. Goda The actin cytoskeleton: integrating form and function at the synapse Annu. Rev. Neurosci. 28 2005 25 55 (Pubitemid 41098898)
31. R. Dixit, J.L. Ross, Y.E. Goldman, and E.L. Holzbaur Differential regulation of dynein and kinesin motor proteins by tau Science 319 2008 1086 1089 (Pubitemid 351300789)
32. D.N. Drechsel, A.A. Hyman, M.H. Cobb, and M.W. Kirschner Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau Mol. Biol. Cell 3 1992 1141 1154 (Pubitemid 23088964)
33. B. Duboff, M. Feany, and J. Gotz Why size matters - balancing mitochondrial dynamics in Alzheimer's disease Trends Neurosci. 36 2013 325 335
34. B. DuBoff, J. Gotz, and M.B. Feany Tau promotes neurodegeneration via DRP1 mislocalization in vivo Neuron 75 2012 618 632
35. M. Dumont, C. Stack, C. Elipenahli, S. Jainuddin, M. Gerges, N.N. Starkova, L. Yang, A.A. Starkov, and F. Beal Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice FASEB J. 25 2011 4063 4072
36. C. Duyckaerts, B. Delatour, and M.C. Potier Classification and basic pathology of Alzheimer disease Acta Neuropathol. 118 2009 5 36
37. K. Eckermann, M.M. Mocanu, I. Khlistunova, J. Biernat, A. Nissen, A. Hofmann, K. Schonig, H. Bujard, A. Haemisch, E. Mandelkow, L. Zhou, G. Rune, and E.M. Mandelkow The beta-propensity of tau determines aggregation and synaptic loss in inducible mouse models of tauopathy J. Biol. Chem. 282 2007 31755 31765 (Pubitemid 350044904)
38. A.E. El-Husseini, E. Schnell, D.M. Chetkovich, R.A. Nicoll, and D.S. Bredt PSD-95 involvement in maturation of excitatory synapses Science 290 2000 1364 1368
39. C.A. Farah, S. Perreault, D. Liazoghli, M. Desjardins, A. Anton, M. Lauzon, J. Paiement, and N. Leclerc Tau interacts with golgi membranes and mediates their association with microtubules Cell Motil. Cytoskeleton 63 2006 710 724 (Pubitemid 44673949)
40. S. Feuillette, L. Miguel, T. Frebourg, D. Campion, and M. Lecourtois Drosophila models of human tauopathies indicate that tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein J. Neurochem. 113 2010 895 903
41. L.M. Fox, C.M. William, D.H. Adamowicz, R. Pitstick, G.A. Carlson, T.L. Spires-Jones, and B.T. Hyman Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model J. Neuropathol. Exp. Neurol. 70 2011 588 595
42. T.A. Fulga, I. Elson-Schwab, V. Khurana, M.L. Steinhilb, T.L. Spires, B.T. Hyman, and M.B. Feany Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo Nat. Cell Biol. 9 2007 139 148 (Pubitemid 46420856)
43. J. Gilley, A. Seereeram, K. Ando, S. Mosely, S. Andrews, M. Kerschensteiner, T. Misgeld, J.P. Brion, B. Anderton, D.P. Hanger, and M.P. Coleman Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse Neurobiol. Aging 33 2012 621.e1-621.e15
44. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, and L. James Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 349 1991 704 706 (Pubitemid 21912142)
45. A. Gomez-Ramos, M. Diaz-Hernandez, A. Rubio, J.I. Diaz-Hernandez, M.T. Miras-Portugal, and J. Avila Characteristics and consequences of muscarinic receptor activation by tau protein Eur. Neuropsychopharmacol. 19 2009 708 717
46. A. Gomez-Ramos, M. Diaz-Hernandez, A. Rubio, M.T. Miras-Portugal, and J. Avila Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells Mol. Cell Neurosci. 37 2008 673 681
47. C. Haass, and E. Mandelkow Fyn-tau-amyloid: a toxic triad Cell 142 2010 356 358
48. D.P. Hanger, B.H. Anderton, and W. Noble Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends Mol. Med. 15 2009 112 119
49. D.P. Hanger, H.L. Byers, S. Wray, K.Y. Leung, M.J. Saxton, A. Seereeram, C.H. Reynolds, M.A. Ward, and B.H. Anderton Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis J. Biol. Chem. 282 2007 23645 23654 (Pubitemid 47311907)
50. J.A. Harris, A. Koyama, S. Maeda, K. Ho, N. Devidze, D.B. Dubal, G.Q. Yu, E. Masliah, and L. Mucke Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits PLoS One 7 2012 e45881
51. L. Hege Nilsen, C. Rae, L.M. Ittner, J. Gotz, and U. Sonnewald Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation J. Cereb. Blood Flow Metab. 33 2013 684 691
52. J.K. Holth, V.C. Bomben, J.G. Reed, T. Inoue, L. Younkin, S.G. Younkin, R.G. Pautler, J. Botas, and J.L. Noebels Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy J. Neurosci. 33 2013 1651 1659
53. B.R. Hoover, M.N. Reed, J. Su, R.D. Penrod, L.A. Kotilinek, M.K. Grant, R. Pitstick, G.A. Carlson, L.M. Lanier, L.L. Yuan, K.H. Ashe, and D. Liao Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration Neuron 68 2010 1067 1081
54. K. Iijima, A. Gatt, and K. Iijima-Ando Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease Hum. Mol. Genet. 19 2010 2947 2957
55. S. Ikegami, A. Harada, and N. Hirokawa Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice Neurosci. Lett. 279 2000 129 132 (Pubitemid 30069810)
56. L.M. Ittner, and J. Gotz Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease Nat. Rev. Neurosci. 12 2011 65 72
57. L.M. Ittner, Y.D. Ke, F. Delerue, M. Bi, A. Gladbach, J. van Eersel, H. Wolfing, B.C. Chieng, M.J. Christie, I.A. Napier, A. Eckert, M. Staufenbiel, E. Hardeman, and J. Gotz Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models Cell 142 2010 387 397
58. M.V. Ivannikov, M. Sugimori, and R.R. Llinas Synaptic vesicle exocytosis in hippocampal synaptosomes correlates directly with total mitochondrial volume J. Mol. Neurosci. 49 2013 223 230
59. O. Katsuse, W.L. Lin, J. Lewis, M.L. Hutton, and D.W. Dickson Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L tau transgenic mice Neurosci. Lett. 409 2006 95 99 (Pubitemid 44637252)
60. Y.D. Ke, A.K. Suchowerska, J. van der Hoven, D.M. De Silva, C.W. Wu, J. van Eersel, A. Ittner, and L.M. Ittner Lessons from tau-deficient mice Int. J. Alzheimer's Dis. 2012 2012 873270
61. W. Kim, S. Lee, C. Jung, A. Ahmed, G. Lee, and G.F. Hall Interneuronal transfer of human tau between Lamprey central neurons in situ J. Alzheimers Dis. 19 2010 647 664
62. K.J. Kopeikina, B.T. Hyman, and T.L. Spires-Jones Soluble forms of tau are toxic in Alzheimer's disease Transl Neurosci. 3 2012 223 233
63. K.J. Kopeikina, M. Polydoro, H.C. Tai, E. Yaeger, G.A. Carlson, R. Pitstick, B.T. Hyman, and T.L. Spires-Jones Synaptic alterations in the rTg4510 mouse model of tauopathy J. Comp. Neurol. 521 2013 1334 1353
64. H.C. Kornau, L.T. Schenker, M.B. Kennedy, and P.H. Seeburg Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95 Science 269 1995 1737 1740
65. G. Lee, S.T. Newman, D.L. Gard, H. Band, and G. Panchamoorthy Tau interacts with src-family non-receptor tyrosine kinases J. Cell Sci. 111 Pt 21 1998 3167 3177 (Pubitemid 28532427)
66. P. Lei, S. Ayton, D.I. Finkelstein, L. Spoerri, G.D. Ciccotosto, D.K. Wright, B.X. Wong, P.A. Adlard, R.A. Cherny, L.Q. Lam, B.R. Roberts, I. Volitakis, G.F. Egan, C.A. McLean, R. Cappai, J.A. Duce, and A.I. Bush Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export Nat. Med. 18 2012 291 295
67. L. Liu, V. Drouet, J.W. Wu, M.P. Witter, S.A. Small, C. Clelland, and K. Duff Trans-synaptic spread of tau pathology in vivo PLoS One 7 2012 e31302
68. Y.H. Liu, B. Giunta, H.D. Zhou, J. Tan, and Y.J. Wang Immunotherapy for Alzheimer disease: the challenge of adverse effects Nat. Rev. Neurol. 8 2012 465 469
69. Q.L. Ma, X. Zuo, F. Yang, O.J. Ubeda, D.J. Gant, M. Alaverdyan, E. Teng, S. Hu, P.P. Chen, P. Maiti, B. Teter, G.M. Cole, and S.A. Frautschy Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice J. Biol. Chem. 288 2013 4056 4065
70. G. Mairet-Coello, J. Courchet, S. Pieraut, V. Courchet, A. Maximov, and F. Polleux The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of abeta oligomers through tau phosphorylation Neuron 78 2013 94 108
71. E.M. Mandelkow, J. Biernat, G. Drewes, N. Gustke, B. Trinczek, and E. Mandelkow Tau domains, phosphorylation, and interactions with microtubules Neurobiol. Aging 16 1995 355 362 discussion 362-353
72. E.M. Mandelkow, K. Stamer, R. Vogel, E. Thies, and E. Mandelkow Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses Neurobiol. Aging 24 2003 1079 1085 (Pubitemid 37487885)
73. E. Masliah, R.D. Terry, R.M. DeTeresa, and L.A. Hansen Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease Neurosci. Lett. 103 1989 234 239 (Pubitemid 19201259)
74. R.A. McKinney Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling J. Physiol. 588 2010 107 116
75. S. Mondragon-Rodriguez, E. Trillaud-Doppia, A. Dudilot, C. Bourgeois, M. Lauzon, N. Leclerc, and J. Boehm Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation J. Biol. Chem. 287 2012 32040 32053
76. H. Moreno, S. Choi, E. Yu, J. Brusco, J. Avila, J.E. Moreira, M. Sugimori, and R.R. Llinas Blocking effects of human tau on squid giant synapse transmission and its prevention by T-817 MA Front Synaptic Neurosci. 3 2011 3
77. L. Mucke, E. Masliah, G.Q. Yu, M. Mallory, E.M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058 (Pubitemid 30365675)
78. P.T. Nelson, I. Alafuzoff, E.H. Bigio, C. Bouras, H. Braak, N.J. Cairns, R.J. Castellani, B.J. Crain, P. Davies, K. Del Tredici, C. Duyckaerts, M.P. Frosch, V. Haroutunian, P.R. Hof, C.M. Hulette, B.T. Hyman, T. Iwatsubo, K.A. Jellinger, G.A. Jicha, E. Kovari, W.A. Kukull, J.B. Leverenz, S. Love, I.R. Mackenzie, D.M. Mann, E. Masliah, A.C. McKee, T.J. Montine, J.C. Morris, J.A. Schneider, J.A. Sonnen, D.R. Thal, J.Q. Trojanowski, J.C. Troncoso, T. Wisniewski, R.L. Woltjer, and T.G. Beach Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature J. Neuropathol. Exp. Neurol. 71 2012 362 381
79. J.M. Nussbaum, S. Schilling, H. Cynis, A. Silva, E. Swanson, T. Wangsanut, K. Tayler, B. Wiltgen, A. Hatami, R. Ronicke, K. Reymann, B. Hutter-Paier, A. Alexandru, W. Jagla, S. Graubner, C.G. Glabe, H.U. Demuth, and G.S. Bloom Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta Nature 485 2012 651 655
80. S. Perreault, O. Bousquet, M. Lauzon, J. Paiement, and N. Leclerc Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau J. Neuropathol. Exp. Neurol. 68 2009 503 514
81. V. Plouffe, N.V. Mohamed, J. Rivest-McGraw, J. Bertrand, M. Lauzon, and N. Leclerc Hyperphosphorylation and cleavage at D421 enhance tau secretion PLoS One 7 2012 e36873
82. M. Polydoro, C.M. Acker, K. Duff, P.E. Castillo, and P. Davies Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology J. Neurosci. 29 2009 10741 10749
83. A.M. Pooler, and D.P. Hanger Functional implications of the association of tau with the plasma membrane Biochem. Soc. Trans. 38 2010 1012 1015
84. A.M. Pooler, E.C. Phillips, D.H. Lau, W. Noble, and D.P. Hanger Physiological release of endogenous tau is stimulated by neuronal activity EMBO Rep. 14 2013 389 394
85. A.M. Pooler, A. Usardi, C.J. Evans, K.L. Philpott, W. Noble, and D.P. Hanger Dynamic association of tau with neuronal membranes is regulated by phosphorylation Neurobiol. Aging 33 431 2012 e427 e438
86. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek, and A. Ferreira Tau is essential to beta -amyloid-induced neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 99 2002 6364 6369 (Pubitemid 34493317)
87. P.H. Reddy Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease Brain Res. 1415 2011 136 148
88. C.H. Reynolds, C.J. Garwood, S. Wray, C. Price, S. Kellie, T. Perera, M. Zvelebil, A. Yang, P.W. Sheppard, I.M. Varndell, D.P. Hanger, and B.H. Anderton Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases J. Biol. Chem. 283 2008 18177 18186
89. E.D. Roberson, K. Scearce-Levie, J.J. Palop, F. Yan, I.H. Cheng, T. Wu, H. Gerstein, G.Q. Yu, and L. Mucke Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model Science 316 2007 750 754 (Pubitemid 46717684)
90. A.B. Rocher, J.L. Crimins, J.M. Amatrudo, M.S. Kinson, M.A. Todd-Brown, J. Lewis, and J.I. Luebke Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs Exp. Neurol. 223 2010 385 393
91. T. Rodriguez-Martin, I. Cuchillo-Ibanez, W. Noble, F. Nyenya, B.H. Anderton, and D.P. Hanger Tau phosphorylation affects its axonal transport and degradation Neurobiol. Aging 34 2013 2146 2157
92. S. Saman, W. Kim, M. Raya, Y. Visnick, S. Miro, B. Jackson, A.C. McKee, V.E. Alvarez, N.C. Lee, and G.F. Hall Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease J. Biol. Chem. 287 2012 3842 3849
93. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K.H. Ashe Tau suppression in a neurodegenerative mouse model improves memory function Science 309 2005 476 481 (Pubitemid 40994688)
94. T. Sapir, M. Frotscher, T. Levy, E.M. Mandelkow, and O. Reiner Tau's role in the developing brain: implications for intellectual disability Hum. Mol. Genet. 21 2012 1681 1692
95. K.L. Schulz, A. Eckert, V. Rhein, S. Mai, W. Haase, A.S. Reichert, M. Jendrach, W.E. Muller, and K. Leuner A new link to mitochondrial impairment in tauopathies Mol. Neurobiol. 46 2012 205 216
96. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791 (Pubitemid 35231524)
97. A. Serrano-Pozo, M.P. Frosch, E. Masliah, and B.T. Hyman Neuropathological alterations in Alzheimer disease Cold Spring Harb Perspect. Med. 1 2011 a006189
98. K. Shahpasand, I. Uemura, T. Saito, T. Asano, K. Hata, K. Shibata, Y. Toyoshima, M. Hasegawa, and S. Hisanaga Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease J. Neurosci. 32 2012 2430 2441
99. 2+-dependent electrostatic switch Neuron 18 1997 133 142 (Pubitemid 27053836)
100. M. Sheng, B.L. Sabatini, and T.C. Sudhof Synapses and Alzheimer's disease Cold Spring Harb Perspect. Biol. 4 2012
101. S. Sivanesan, A. Tan, and J. Rajadas Pathogenesis of abeta oligomers in synaptic failure Curr. Alzheimer Res. 10 2013 316 323
102. B. Solomon, and D. Frenkel Immunotherapy for Alzheimer's disease Neuropharmacology 59 2010 303 309
103. S. Souter, and G. Lee Tubulin-independent tau in Alzheimer's disease and cancer: implications for disease pathogenesis and treatment Curr. Alzheimer Res. 7 2010 697 707
104. T.L. Spires, J.D. Orne, K. SantaCruz, R. Pitstick, G.A. Carlson, K.H. Ashe, and B.T. Hyman Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy Am. J. Pathol. 168 2006 1598 1607
105. T.L. Spires-Jones, K.J. Kopeikina, R.M. Koffie, A. de Calignon, and B.T. Hyman Are tangles as toxic as they look? J. Mol. Neurosci. 45 2011 438 444
106. K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E.M. Mandelkow Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress J. Cell Biol. 156 2002 1051 1063 (Pubitemid 34839854)
107. T. Sun, H. Qiao, P.Y. Pan, Y. Chen, and Z.H. Sheng Motile axonal mitochondria contribute to the variability of presynaptic strength Cell Rep. 4 2013 413 419
108. A. Sydow, A. Van der Jeugd, F. Zheng, T. Ahmed, D. Balschun, O. Petrova, D. Drexler, L. Zhou, G. Rune, E. Mandelkow, R. D'Hooge, C. Alzheimer, and E.M. Mandelkow Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant J. Neurosci. 31 2011 2511 2525
109. C. Tackenberg, S. Grinschgl, A. Trutzel, A.C. Santuccione, M.C. Frey, U. Konietzko, J. Grimm, R. Brandt, and R.M. Nitsch NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss Cell Death Dis. 4 2013 e608
110. H.C. Tai, A. Serrano-Pozo, T. Hashimoto, M.P. Frosch, T.L. Spires-Jones, and B.T. Hyman The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system Am. J. Pathol. 181 2012 1426 1435
111. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
112. C.H. Trepanier, M.F. Jackson, and J.F. MacDonald Regulation of NMDA receptors by the tyrosine kinase Fyn FEBS J. 279 2012 12 19
113. A. Usardi, A.M. Pooler, A. Seereeram, C.H. Reynolds, P. Derkinderen, B. Anderton, D.P. Hanger, W. Noble, and R. Williamson Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau FEBS J. 278 2011 2927 2937
114. M.A. Utton, W.J. Noble, J.E. Hill, B.H. Anderton, and D.P. Hanger Molecular motors implicated in the axonal transport of tau and alpha-synuclein J. Cell Sci. 118 2005 4645 4654 (Pubitemid 41646375)
115. A. Van der Jeugd, K. Hochgrafe, T. Ahmed, J.M. Decker, A. Sydow, A. Hofmann, D. Wu, L. Messing, D. Balschun, R. D'Hooge, and E.M. Mandelkow Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau Acta Neuropathol. 123 2012 787 805
116. M. Vos, E. Lauwers, and P. Verstreken Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease Front Synaptic Neurosci. 2 2010 139
117. X. Wang, B. Su, H.G. Lee, X. Li, G. Perry, M.A. Smith, and X. Zhu Impaired balance of mitochondrial fission and fusion in Alzheimer's disease J. Neurosci. 29 2009 9090 9103
118. P.J. Yao, M. Zhu, E.I. Pyun, A.I. Brooks, S. Therianos, V.E. Meyers, and P.D. Coleman Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease Neurobiol. Dis. 12 2003 97 109 (Pubitemid 36355860)
119. Y.J. Yu, and R.J. Watts Developing therapeutic antibodies for neurodegenerative disease Neurotherapeutics 10 2013 459 472
120. (2+) elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines J. Neurosci. 30 2010 11938 11950